N-[(1S)-2-cyclopropyl-1-[1-methyl-5-(trifluoromethoxy)benzimidazol-2-yl]ethyl]-5-methylpyrazine-2-carboxamide
C20H20F3N5O2 — CID 171534700
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(1S)-2-cyclopropyl-1-[1-methyl-5-(trifluoromethoxy)benzimidazol-2-yl]ethyl]-5-methylpyrazine-2-carboxamide
N-[(1S)-2-cyclopropyl-1-[1-methyl-5-(trifluoromethoxy)benzimidazol-2-yl]ethyl]-5-methylpyrazine-2-carboxamide (PubChem CID 171534700) has the molecular formula C20H20F3N5O2 and a molecular weight of 419.41 g/mol. Its IUPAC name is N-[(1S)-2-cyclopropyl-1-[1-methyl-5-(trifluoromethoxy)benzimidazol-2-yl]ethyl]-5-methylpyrazine-2-carboxamide.
Molecular Properties
| Compound Name | N-[(1S)-2-cyclopropyl-1-[1-methyl-5-(trifluoromethoxy)benzimidazol-2-yl]ethyl]-5-methylpyrazine-2-carboxamide |
|---|---|
| PubChem CID | 171534700 |
| Molecular Formula | C20H20F3N5O2 |
| Molecular Weight | 419.41 g/mol |
| Exact Mass | 419.16 |
| IUPAC Name | N-[(1S)-2-cyclopropyl-1-[1-methyl-5-(trifluoromethoxy)benzimidazol-2-yl]ethyl]-5-methylpyrazine-2-carboxamide |
| SMILES | Cc1cnc(C(=O)N[C@@H](CC2CC2)c2nc3cc(OC(F)(F)F)ccc3n2C)cn1 |
| InChI | InChI=1S/C20H20F3N5O2/c1-11-9-25-16(10-24-11)19(29)27-15(7-12-3-4-12)18-26-14-8-13(30-20(21,22)23)5-6-17(14)28(18)2/h5-6,8-10,12,15H,3-4,7H2,1-2H3,(H,27,29)/t15-/m0/s1 |
| InChIKey | LTHCTWNYZRKUNE-HNNXBMFYSA-N |
| XLogP | 3.84 |
| TPSA | 81.93 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 419.41 |
| LogP ≤ 5 | 3.84 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171534700 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.